There is a recent and growing resurgence of interest in the potential for psychedelic compounds to be utilized as treatments for mood and anxiety disorders when administered in the context of a psychotherapeutic regimen. Chief among the substances most extensively studied is psilocybin, a compound originally derived from a genus of mushrooms that occurs naturally in most continents across the…
Do you worry excessively? Does your mind race with if thoughts? Do you anticipate awful outcomes and feel the need to think about them repeatedly? ADAA Board Member, Ken Goodman, will explain why people worry, why it triggers physical symptoms of anxiety, and what people can do about it. He will be joined by a former worrier who will share how she gained control of the incessant inner-chatter…
Common Psychopathology: What Can the Past Tell us About the Future?
Sheraton Denver Downtown Hotel 1550 Court Place, Denver, CO 80202
Join more than 1,000 clinicians and researchers from across the US and around the world for vibrant programming, impactful connections with peers, and access to…
ADAA is not a direct service organization. ADAA does not provide psychiatric, psychological, or medical advice, diagnosis, or treatment.
Founded in 1979, ADAA is an international nonprofit organization dedicated to the prevention, treatment, and cure of anxiety, depression, OCD, PTSD, and co-occurring disorders through aligning research, practice and education.
